Project Grant HT94252510773
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$818K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45220, USA
Similar Awards
This $1,561,794 Project Grant was awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports research led by the University of Cincinnati to investigate the role of plasmacytoid dendritic cells (pDCs) in immune suppression and treatment resistance in acute myeloid leukemia. The award will fund a 3-year research project from September 2024 through August 2027 to advance the scientific understanding of how pDCs...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,342,184.00 to the University of Cincinnati to conduct research on "STATHMIN POST-TRANSLATIONAL PROCESSING AS A MECHANISM OF CASTRATION RESISTANCE." The project aims to investigate this biological mechanism with the potential to yield new treatments for military-relevant medical conditions. The award has a performance...
This federal Project Grant award for $1,399,812.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant is awarded to the Regents of the University of Minnesota to conduct research on outcomes and late effects in pediatric and adolescent germ cell tumor survivors. This funding will enable...
The University of Cincinnati received a $243,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Characterization of Novel Perivascular Lesions Caused by Specific Deletion of TSC2 in Hematopoietic Cells." The award period is from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program supports biomedical research aimed at improving the...
The federal Project Grant award of $810,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research on "EARLY NEUROMODULATION FOR COGNITIVE RECOVERY AND REHABILITATION IN TRAUMATIC BRAIN INJURY" at the University of Cincinnati. The grant, awarded on Nov 1, 2024, with a completion date of Oct 31, 2027, will fund scientific investigations exploring innovative approaches to disease prevention, diagnosis, treatment,...
This federal Project Grant award of $999,999.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research into cell-free DNA epigenetic biomarkers for multiple sclerosis. The award was granted on August 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The project aims to transform healthcare for military service...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $869,193 to the University of Chicago to conduct research on identifying the pathogenesis of monosomy 7 in bone marrow failure. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical discoveries in this specialized medical domain. The award has a performance period...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
The federal Project Grant award, valued at $1,312,000.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support research strategies to upregulate and image Nectin4 to enhance Nectin4-targeted therapies in bladder cancer. The research, to be conducted by The Regents of the University of California, San Francisco (UCSF) from August 1, 2025 to July 31, 2029, aims to transform healthcare for military service members, veterans,...
This federal Project Grant award, with a total funding amount of $480,313, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award will support research conducted by Duke University, a leading private research institution, to investigate NUAK2 as a novel splicing regulatory kinase in neuroendocrine prostate cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by...